EYE
Overvalued by 23% based on the discounted cash flow analysis.
Market cap | $1.40 Billion |
---|---|
Enterprise Value | $1.71 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.84 |
Beta | 0.0 |
Outstanding Shares | 78,312,620 |
Avg 30 Day Volume | 1,004,563 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -21.24 |
---|---|
PEG | -29.24 |
Price to Sales | 0.66 |
Price to Book Ratio | 1.79 |
Enterprise Value to Revenue | 0.8 |
Enterprise Value to EBIT | 48.3 |
Enterprise Value to Net Income | -26 |
Total Debt to Enterprise | 0.27 |
Debt to Equity | 0.56 |
No data
No data